ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,433.74
0.23%
Dow Jones
38,647.10
-0.17%
US Dollar vs MXN
18.4103
-0.07%
Brent Oil
82.12
0.18%
Bitcoin
66,714.25
-0.06%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Noticias

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TNXP
FechaHoraFuenteTítuloSímboloCompañía
13/06/202416:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/06/202416:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/06/202416:01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/06/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/06/202416:17GlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202410:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock SplitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/06/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
05/06/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
03/06/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/05/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/05/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International ConventionNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/05/202416:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
22/05/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/05/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
15/05/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/05/202415:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/05/202415:30GlobeNewswire Inc.Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/04/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at Planet MicroCap ShowcaseNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/04/202415:15GlobeNewswire Inc.Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/03/202408:32GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at BIO-Europe SpringNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/03/202408:37GlobeNewswire Inc.New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
07/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of TherapyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/202416:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/03/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Su Consulta Reciente

DBI
I1U8
XTEUHYCBUEUSDINAV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados